首頁 > 市場調查報告書 > 製藥

動物用醫藥

口蹄疫（FMD）市場規模、佔有率和成長分析（按疫苗類型、動物種類、通路和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900359

口蹄疫（FMD）市場規模、佔有率和成長分析（按疫苗類型、動物種類、通路和地區分類）－2026-2033年產業預測

FMD Disease Market Size, Share, and Growth Analysis, By Vaccine Type (Conventional vaccines, Emergency vaccines), By Animal Type (Cattle, Sheep & goat), By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，口蹄疫 (FMD) 市場規模將達到 34.8 億美元，到 2025 年將成長至 37.9 億美元，到 2033 年將成長至 74.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 8.8%。

口蹄疫市場分析顯示，獸用疫苗需求顯著成長，主要受動物性食品消費量上升和牲畜數量增加的推動。這一趨勢與牲畜和通用感染疾病的增加密切相關，而環境變化和快速全球化加劇了這一趨勢。世界各國政府優先考慮對牲畜和伴侶動物採取有效的醫療控制措施，以減輕疾病爆發對國家GDP的經濟影響。由於缺乏特效治療方法且感染途徑多樣，疫苗接種策略的重要性凸顯。隨著動物產品需求的飆升，相關人員必須加大對口蹄疫防治的投入。同時，採取嚴格動物衛生措施的地區已成功控制了口蹄疫，從而降低了對疫苗的迫切需求。

口蹄疫（FMD）疾病市場促進因素

動物性蛋白質和乳製品消費量的成長是口蹄疫市場的主要促進因素。隨著全球人口的成長，對畜產品的需求也隨之增加，因此，應對口蹄疫的影響至關重要，因為口蹄疫可能會對畜牧業造成巨大的經濟損失。為了滿足這項需求，確保牲畜健康是重中之重，因為口蹄疫疫情會阻礙生產並擾亂供應鏈。因此，重視疾病預防和控制策略對於維護牲畜健康以及支持整個肉類和乳製品行業的成長至關重要。

口蹄疫市場限制

與口蹄疫疫苗和診斷試劑相關的經濟負擔構成了巨大的市場挑戰，尤其是在牲畜存欄量大規模的開發中國家。採購和實施這些必要的預防措施的成本可能會限制農民和畜牧生產者獲得這些措施的機會，而他們本來就面臨經濟困難。該地區資源和資金的匱乏進一步加劇了這種情況，使得相關人員難以實施有效的口蹄疫控制措施。因此，這些經濟限制會阻礙疾病防治工作，進而影響牲畜的整體健康和生產力。

口蹄疫市場趨勢

口蹄疫疫苗市場呈現顯著成長趨勢，尤其是在畜牧業是重要經濟活動的開發中國家。這項需求激增主要得益於各國主導積極採取措施控制和預防口蹄疫疫情。隨著人們對口蹄疫對牲畜健康和農業生產力影響的認知不斷提高，各國政府正加大對疫苗接種計畫的投入，以保護動物福利並確保糧食安全。此外，公私部門在疫苗研發和分發方面的合作也進一步推動了市場成長，反映了各方為減輕口蹄疫經濟影響而做出的共同努力。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Boehringer Ingelheim（Germany）
Merck Animal Health（USA）
Zoetis（USA）
MSD Animal Health（USA）
Elanco Animal Health（USA）
Ceva Sante Animale（France）
Virbac（France）
Indian Immunologicals Limited（India）
Biogenesis Bago（Argentina）
FMD Center World Reference Laboratory（UK）
TAD Pharma GmbH（Germany）
Vetoquinol（France）
Phibro Animal Health Corporation（USA）
Tiankang Bio（China）
Ringpu Biology（China）
CAVAC（China）
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna（Italy）
Korea Animal Health Products Association（Korea）
CZ Veterinaria（Spain）

結論與建議

簡介目錄

Product Code: SQMIG35E2021

FMD Disease Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.79 Billion in 2025 to USD 7.43 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

Market insights into foot-and-mouth disease (FMD) reveal a significant increase in the demand for veterinary vaccines, largely driven by the growing consumption of animal products and an expanding livestock population. This trend is closely linked to the rise of livestock and zoonotic diseases, exacerbated by environmental changes and rapid globalization. Governments worldwide are prioritizing effective medical practices for both livestock and companion animals to mitigate the economic impacts of disease outbreaks on national GDPs. The absence of definitive cures and multiple infection pathways underscored the critical need for vaccination strategies. As animal product demands surge, investment in FMD prevention becomes essential for stakeholders. In contrast, regions with stringent animal health measures have successfully controlled FMD, reducing the immediate necessity for vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the FMD Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

FMD Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the FMD Disease Market

The increasing consumption of animal protein and dairy products serves as a significant catalyst for the FMD (Foot-and-Mouth Disease) market. As the global population continues to rise, so does the need for livestock, which makes it crucial to address the impacts of FMD, a disease that can result in substantial economic losses within the livestock sector. Ensuring the health of livestock is paramount to meeting this demand, as outbreaks of FMD can hinder production levels and disrupt supply chains. Consequently, the focus on disease prevention and management strategies becomes essential for maintaining livestock health and supporting the overall growth of the meat and dairy industries.

Restraints in the FMD Disease Market

The financial burden associated with vaccines and diagnostic tests for foot-and-mouth disease (FMD) poses a significant challenge for the market, especially in developing nations that boast substantial livestock herds. The expense involved in acquiring and administering these essential preventative measures can limit accessibility for farmers and livestock producers who may already be facing economic hardships. This situation is exacerbated by limited resources and funding in these regions, making it difficult for stakeholders to implement effective FMD control strategies. Consequently, these financial constraints can hinder efforts to manage and mitigate the spread of the disease, affecting overall livestock health and productivity.

Market Trends of the FMD Disease Market

The FMD disease market is witnessing a notable trend characterized by a rising demand for FMD vaccines, particularly in developing nations where livestock farming is a vital economic activity. This surge is largely driven by proactive government initiatives aimed at controlling and preventing foot-and-mouth disease outbreaks. As awareness of the disease's impact on livestock health and agricultural productivity grows, authorities are increasingly investing in vaccination programs to safeguard animal welfare and ensure food security. Additionally, the collaboration between public and private sectors in vaccine development and distribution is further bolstering market growth, reflecting a concerted effort to mitigate the economic repercussions of FMD.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2026-2033)

Market Overview
Conventional vaccines
- Aluminium hydroxide & saponin-based vaccines
- Oil-based vaccines
Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2026-2033)

Market Overview
Cattle
Sheep & goat
Pig
Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Veterinary hospitals & clinics
Government institutions
Retail pharmacies
Online pharmacies

Global FMD Disease Market Size & CAGR (2026-2033)

North America (Vaccine Type, Animal Type, Distribution Channel)
- US
- Canada
Europe (Vaccine Type, Animal Type, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, Animal Type, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MSD Animal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis Bago (Argentina)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FMD Center World Reference Laboratory (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TAD Pharma GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phibro Animal Health Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tiankang Bio (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ringpu Biology (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CAVAC (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Korea Animal Health Products Association (Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CZ Veterinaria (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments